NEURALGLIDER® PRECISION BRAIN ACCESS PLATFORM
Precision Brain Access for Deep Brain Therapies
Actuated Medical has developed and validated the NeuralGlider® Precision Brain Access Platform, that assists neurological and longevity therapies to achieve their intended therapeutic effect by improving access to deep brain targets and supporting more effective delivery of brain-directed therapies.
THE BOTTLENECK
The Bottleneck in Brain Therapeutics Is Not Only Biology — It Is Delivery
Breakthrough brain therapies are advancing rapidly, but their success depends on accurate delivery to precise brain targets. Even when the biological target is validated and the therapeutic payload is effective, clinical benefit can be limited if the therapy, implant, or device does not reach its intended location.
Actuated Medical is addressing this fundamental challenge with a developed and preclinically validated platform for precision brain access.
THE PLATFORM
Introducing the NeuralGlider® Precision Brain Access Platform
The NeuralGlider® platform uses electronically controlled ultrasonic motion to help maintain the desired trajectory during insertion through delicate brain tissue. In non-human primate studies, it has supported precise delivery to deep brain targets, including AAV gene therapy, while enabling smaller-diameter cannulas that may reduce reflux along the insertion track.
- NHelps maintain the desired trajectory during insertion
- NSupports precise access to deep brain targets
- NEnables smaller-diameter cannulas for certain delivery applications
- NMay reduce tissue trauma and therapeutic reflux
- NApplicable across multiple brain-directed therapy categories